Given the association of elevated ISG expression with ADAR dependence, and chordoma cells’ selective dependence on ADAR relative to non-chordoma cancer cell lines, we compared the expression of ISGs in chordoma cells versus that of other cancer types using a previously described 38-gene signature quantifying IFN pathway engagement (“ISG core score”)37. This evidence concerns the gene ADAR and cancer.